» Articles » PMID: 18188933

In Vitro Analysis of Ribozyme-mediated Knockdown of an ADRP Associated Rhodopsin Mutation

Overview
Date 2008 Jan 15
PMID 18188933
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Wild-type opsin does not aggregate with a misfolded opsin mutant.

Gragg M, Kim T, Howell S, Park P Biochim Biophys Acta. 2016; 1858(8):1850-9.

PMID: 27117643 PMC: 4900927. DOI: 10.1016/j.bbamem.2016.04.013.


Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Conley S, Naash M Cold Spring Harb Perspect Med. 2014; 4(11):a017376.

PMID: 25167981 PMC: 4208711. DOI: 10.1101/cshperspect.a017376.


Gene therapy in animal models of autosomal dominant retinitis pigmentosa.

Rossmiller B, Mao H, Lewin A Mol Vis. 2012; 18:2479-96.

PMID: 23077406 PMC: 3472929.

References
1.
Cashman S, Binkley E, Kumar-Singh R . Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference. Gene Ther. 2005; 12(15):1223-8. DOI: 10.1038/sj.gt.3302512. View

2.
Sung C, Davenport C, Nathans J . Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J Biol Chem. 1993; 268(35):26645-9. View

3.
Liu J, Timmers A, Lewin A, Hauswirth W . Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice. Invest Ophthalmol Vis Sci. 2005; 46(10):3836-44. DOI: 10.1167/iovs.04-1283. View

4.
Tam B, Moritz O . Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2006; 47(8):3234-41. DOI: 10.1167/iovs.06-0213. View

5.
Bumcrot D, Manoharan M, Koteliansky V, Sah D . RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol. 2006; 2(12):711-9. PMC: 7097247. DOI: 10.1038/nchembio839. View